Skip to main content
. 2024 Mar 15;16(3):988–997. doi: 10.62347/CBKR4894

Table 7.

Delong test

Marker 1 Marker 2 Z value P value AUC difference 95% CI
MELD before treatment Pre-treatment TNF-α (pg/mL) 1.781 0.075 0.021 -0.002-0.043
MELD before treatment IL-33 before treatment (pg/mL) 4.22 <0.001 0.108 0.058-0.158
MELD before treatment MIP-1α before treatment (pg/mL) 4.753 <0.001 0.111 0.065-0.156
Pre-treatment TNF-α (pg/mL) IL-33 before treatment (pg/mL) 4.474 <0.001 0.087 0.049-0.126
Pre-treatment TNF-α (pg/mL) Pre-treatment MIP-1α (pg/mL) 5.084 <0.001 0.09 0.055-0.125
IL-33 before treatment (pg/mL) Pre-treatment MIP-1α (pg/mL) 0.301 0.763 0.003 -0.016-0.021

Note: MELD, Model for End-Stage Liver Disease; TNF-α, Tumor Necrosis Factor-α; IL-33, Interleukin-33; MIP-1α, Macrophage Inflammatory Protein-1α.